1,2,3,4-tetrahydroquinoline has been researched along with Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuya, K; Kawai, K; Miyakawa, M; Nagata, N; Nishiyama, D; Oguro, N; Ohyabu, Y; Satsukawa, M; Yamamoto, N | 1 |
| Amano, S; Furuya, K; Inoguchi, K; Miyakawa, M; Nagata, N; Nejishima, H; Yamamoto, N | 1 |
2 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Osteoporosis
| Article | Year |
|---|---|
Lead evaluation of tetrahydroquinolines as nonsteroidal selective androgen receptor modulators for the treatment of osteoporosis.
Topics: Animals; Binding Sites; Caco-2 Cells; Crystallography, X-Ray; Disease Models, Animal; Drug Design; Female; Half-Life; Humans; Hydrogen Bonding; Molecular Docking Simulation; Niacinamide; Osteoporosis; Protein Structure, Tertiary; Quinolines; Rats; Receptors, Androgen; Testosterone Congeners; Thermodynamics | 2014 |
Tetrahydroquinolines as a novel series of nonsteroidal selective androgen receptor modulators: structural requirements for better physicochemical and biological properties.
Topics: Animals; Bone Density; Female; Osteoporosis; Ovariectomy; Quinolines; Rats; Receptors, Androgen | 2011 |